iRadimed Q3 2024 Adj. EPS $0.43 Beats $0.39 Estimate, Sales $18.326M Beat $18.098M Estimate
Portfolio Pulse from Benzinga Newsdesk
iRadimed (NASDAQ:IRMD) reported Q3 2024 earnings per share of $0.43, surpassing the analyst estimate of $0.39. The company's sales reached $18.326 million, exceeding the expected $18.098 million and marking an 11.04% increase from the previous year.
October 31, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
iRadimed's Q3 2024 earnings and sales exceeded analyst expectations, with EPS at $0.43 and sales at $18.326 million, indicating strong financial performance.
iRadimed's earnings per share and sales both exceeded analyst expectations, which is typically a positive indicator for stock performance. The 11.04% year-over-year sales increase further supports a positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100